🔧На сайте запланированы технические работы
25.12.2025 в промежутке с 18:00 до 21:00 по Московскому времени (GMT+3) на сайте будут проводиться плановые технические работы. Возможны перебои с доступом к сайту. Приносим извинения за временные неудобства. Благодарим за понимание!
🔧Site maintenance is scheduled.
Scheduled maintenance will be performed on the site from 6:00 PM to 9:00 PM Moscow time (GMT+3) on December 25, 2025. Site access may be interrupted. We apologize for the inconvenience. Thank you for your understanding!

 

Effect of Vascular Endothelial Growth Factor and Erythropoietin on Functional Activity of Fibroblasts and Multipotent Mesenchymal Stromal Cells


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

The study examined the effect of VEGF and erythropoietin on proliferative and migratory activities of skin fibroblasts and multipotent mesenchymal stromal cells of human adipose tissue. VEGF stimulated proliferation and migration of fi broblasts, but produced no significant effect on functional activity of multipotent mesenchymal stem cells. Erythropoietin stimulated proliferation of both cell types, but did not affect their migration.

Авторлар туралы

N. Bondarenko

Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation

Хат алмасуға жауапты Автор.
Email: bond802888@yandex.ru
Ресей, Moscow; Novosibirsk

Yu. Nikonorova

Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences

Email: bond802888@yandex.ru
Ресей, Moscow

M. Surovtseva

Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences

Email: bond802888@yandex.ru
Ресей, Moscow

A. Lykov

Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation

Email: bond802888@yandex.ru
Ресей, Moscow; Novosibirsk

O. Poveshchenko

Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation

Email: bond802888@yandex.ru
Ресей, Moscow; Novosibirsk

A. Poveshchenko

Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation

Email: bond802888@yandex.ru
Ресей, Moscow; Novosibirsk

E. Pokushalov

E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation

Email: bond802888@yandex.ru
Ресей, Novosibirsk

A. Romanov

E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation

Email: bond802888@yandex.ru
Ресей, Novosibirsk

V. Konenkov

Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation

Email: bond802888@yandex.ru
Ресей, Moscow; Novosibirsk

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Springer Science+Business Media New York, 2016